Article

Bascom Palmer names Eduardo C. Alfonso, MD, its new chairman

Eduardo C. Alfonso, MD, is the new chairman of the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Alfonso is the fifth chairman to be named in the institute's 47-year history.

Miami-Eduardo C. Alfonso, MD, is the new chairman of the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Alfonso is the fifth chairman to be named in the institute’s 47-year history.

Dr. Alfonso is a cornea specialist with a special interest in corneal transplants. He is the medical director of Bascom Palmer’s Ocular Microbiology Laboratory.

Dr. Alfonso grew up in Puerto Rico before moving to the United States to attend college. A graduate of Yale College (Summa Cum Laude, Phi Beta Kappa) and the Yale University School of Medicine, Dr. Alfonso first joined the Bascom Palmer Eye Institute in 1981 as an ophthalmology resident. He completed fellowships at Harvard Medical School in Boston; corneal and external diseases at the Massachusetts Eye & Ear Infirmary; ophthalmic pathology at the David G. Cogan Eye Pathology Laboratory; and research at the Howe Laboratory of Ophthalmology. He joined the Bascom Palmer Eye Institute faculty in 1986 as assistant professor and became professor of ophthalmology and the Edward W.D. Norton Professor in Ophthalmology in 1998. He now will hold the Kathleen and Stanley J. Glaser Chair in Ophthalmology.

“The University of Miami Miller School of Medicine is indeed fortunate to have someone as talented as [Dr. Alfonso] at the helm of Bascom Palmer. His intellect, integrity, and vision make him the perfect choice to lead the nation’s best eye hospital into the 21st century,” said Pascal J. Goldschmidt, MD, senior vice president for medical affairs and dean of the University of Miami Miller School of Medicine and chief executive officer of the University of Miami Health System, who announced the appointment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.